Liraglutide
SCALE™ IBT
Novo Nordisk · Phase 3 · Completed · Enrollment 282
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Liraglutide | Obesity or overweight | n/r | 56 | Efficacy | n/r |
| Placebo | Obesity or overweight | n/r | 56 | Efficacy | n/r |
| Liraglutide 3.0 mg, in trial | Obesity or overweight | 3.0 mg | 56 | ITT | n/r |
| Placebo, in trial | Obesity or overweight | n/r | 56 | ITT | n/r |